X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
index medicus (12) 12
male (11) 11
middle aged (11) 11
female (10) 10
aged (9) 9
adult (8) 8
hematology (8) 8
treatment outcome (7) 7
prospective studies (6) 6
chemotherapy (5) 5
stem cells (5) 5
adolescent (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
follow-up studies (4) 4
rituximab (4) 4
transplantation (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer (3) 3
care and treatment (3) 3
disease (3) 3
hodgkin disease - drug therapy (3) 3
lymphomas (3) 3
survival analysis (3) 3
young adult (3) 3
activation (2) 2
anthracyclines (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, murine-derived (2) 2
autoimmune hemolytic anemia (2) 2
autologous transplantation (2) 2
bone-marrow-transplantation (2) 2
case report (2) 2
chronic lymphocytic leukemia (2) 2
conditioning regiment (2) 2
dose-response relationship, drug (2) 2
doxorubicin - administration & dosage (2) 2
fotemustine (2) 2
graft survival (2) 2
haematological malignancy (2) 2
hematopoietic stem cell transplantation - methods (2) 2
high-dose melphalan (2) 2
hodgkin disease - pathology (2) 2
hodgkin lymphoma (2) 2
italy - epidemiology (2) 2
kaplan-meier estimate (2) 2
knee (2) 2
liver cirrhosis - epidemiology (2) 2
medicine & public health (2) 2
melphalan - administration & dosage (2) 2
melphalan - adverse effects (2) 2
multiple myeloma (2) 2
nitrosourea compounds - adverse effects (2) 2
non-hodgkin's lymphomas (2) 2
non-hodgkins-lymphoma (2) 2
oncology (2) 2
organophosphorus compounds - adverse effects (2) 2
orthopedics (2) 2
prognosis (2) 2
randomized-trial (2) 2
registries (2) 2
risk (2) 2
salvage therapy (2) 2
salvage therapy - methods (2) 2
stem-cell-transplantation (2) 2
surgery (2) 2
thiotepa (2) 2
thrombosis (2) 2
transplantation conditioning - methods (2) 2
transplantation, autologous (2) 2
2 nitrosoureas (1) 1
200 mg/m melphalan (1) 1
abvd (1) 1
acl reconstruction (1) 1
age factors (1) 1
aged patients (1) 1
aggressive lymphoma (1) 1
alkyltransferase (1) 1
alta (1) 1
american-college (1) 1
analysis (1) 1
analysis of variance (1) 1
anemia, hemolytic, autoimmune - complications (1) 1
anemia, hemolytic, autoimmune - diagnosis (1) 1
anemia, hemolytic, autoimmune - drug therapy (1) 1
anterior cruciate ligament (1) 1
anterior cruciate ligament - diagnostic imaging (1) 1
anterior cruciate ligament - surgery (1) 1
anterior cruciate ligament injuries (1) 1
anthracycline-induced cardiotoxicity (1) 1
anti-cd20 (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
anticoagulants (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2009, Volume 64, Issue 5, pp. 907 - 916
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1932 - 1938
Abstract High-dose melphalan (MEL) is the standard therapy for autologous stem cell transplantation (ASCT) in multiple myeloma (MM), although the optimal... 
Hematology, Oncology and Palliative Medicine | Conditioning regiment | High-dose melphalan | Autologous transplantation | Thiotepa | Multiple myeloma
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 11/2015, Volume 21, Issue 11, pp. 1932 - 1938
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2016, Volume 172, Issue 1, pp. 111 - 121
High‐dose chemotherapy ( HDT ) with autologous stem cell transplantation is the standard of care for relapsed/refractory ( RR ) Hodgkin lymphoma ( HL ). Given... 
high‐dose chemotherapy | fotemustine | autologous stem cell transplantation | Hodgkin lymphoma | High-dose chemotherapy | Autologous stem cell transplantation | Fotemustine | FDG-PET | fote-mustine | PULMONARY TOXICITY | PROGNOSTIC-FACTORS | BONE-MARROW-TRANSPLANTATION | STEM-CELL-TRANSPLANTATION | BRENTUXIMAB VEDOTIN | PREPARATIVE REGIMENS | RANDOMIZED-TRIAL | CONDITIONING REGIMEN | SALVAGE THERAPY | HEMATOLOGY | high-dose chemotherapy | Drug Evaluation - methods | Hodgkin Disease - diagnostic imaging | Nitrosourea Compounds - administration & dosage | Nitrosourea Compounds - adverse effects | Salvage Therapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Cytarabine - adverse effects | Young Adult | Melphalan - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Registries | Transplantation Conditioning - methods | Child | Organophosphorus Compounds - adverse effects | Etoposide - adverse effects | Kaplan-Meier Estimate | Etoposide - administration & dosage | Graft Survival | Treatment Outcome | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Aged | Organophosphorus Compounds - administration & dosage | Hematopoietic Stem Cell Transplantation - methods | Salvage Therapy - methods | Chemotherapy | Lymphomas | Patient outcomes | Stem cells | Cancer | Index Medicus | Research Paper | Haematological Malignancy
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2011, Volume 154, Issue 5, pp. 579 - 589
This Phase II study assessed feasibility and efficacy of a biweekly R‐COMP‐14 regimen (rituximab, cyclophosphamide, non‐pegylated liposome‐encapsulated... 
non‐pegylated liposomal doxorubicin | cardiotoxicity | diffuse large B‐cell lymphoma | Charlson Comorbidity Index | elderly | Cardiotoxicity | Elderly | Non-pegylated liposomal doxorubicin | Diffuse large B-cell lymphoma | GUIDELINE UPDATE | AMERICAN-COLLEGE | diffuse large B-cell lymphoma | non-pegylated liposomal doxorubicin | CARDIAC-DISEASES | LEFT-VENTRICULAR DYSFUNCTION | OLDER PATIENTS | SEPTIC SHOCK | NON-HODGKINS-LYMPHOMA | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | ASSOCIATION TASK-FORCE | AGGRESSIVE LYMPHOMA | HEMATOLOGY | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Comorbidity | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Rituximab | Lymphoma, Large B-Cell, Diffuse - complications | Male | Risk | Treatment Outcome | Polyethylene Glycols - administration & dosage | Heart Diseases - epidemiology | Doxorubicin - analogs & derivatives | Survival Analysis | Aged, 80 and over | Vincristine - administration & dosage | Female | Aged | Heart Diseases - drug therapy | Doxorubicin - administration & dosage | Anthracyclines | Cyclophosphamide | Corticosteroids | Stem cells | Aged patients | Transplantation | Lymphomas | Prednisone | Steroids | Index Medicus | Haematological Malignancy
Journal Article
by Basili, S and Raparelli, V and Napoleone, L and Talerico, G and Corazza, G.R and Perticone, F and Sacerdoti, D and Andriulli, A and Licata, A and Pietrangelo, A and Picardi, A and Raimondo, G and Violi, F and Palasciano, Giuseppe and D’Alitto, Felicia and Palmieri, Vincenzo Ostilio and Santovito, Daniela and Di Michele, Dario and Croce, Giuseppe and Brocco, Silvia and Fasolato, Silvano and Cecchetto, Lara and Bombonato, Giancarlo and Bertoni, Michele and Restuccia, Tea and Andreozzi, Paola and Liguori, Maria Livia and Caroleo, Benedetto and Perticone, Maria and Staltari, Orietta and Manfredini, Roberto and De Giorgi, Alfredo and Averna, Maurizio and Giammanco, Antonina and Granito, Alessandro and Pettinari, Irene and Marinelli, Sara and Bolondi, Luigi and Falsetti, Lorenzo and Salvi, Aldo and Durante-Mangoni, Emanuele and Cesaro, Flavio and Farinaro, Vincenza and Ragone, Enrico and Morana, Ignazio and Ippolito, Antonio and Iacobellis, Angelo and Niro, Grazia and Merla, Antonio and Maimone, Sergio and Cacciola, Irene and Varvara, Doriana and Drenaggi, Davide and Staffolani, Silvia and Vespasiani-Gentilucci, Umberto and Galati, Giovanni and Gallo, Paolo and Davì, Giovanni and Schiavone, Cosima and Santilli, Francesca and Tana, Claudio and Soresi, Maurizio and Bianchi Giovanni, Battista and Carderi, Isabella and Pinto, Antonio and Tuttolomondo, Antonino and Ferrari, Giovanni and Gresele, Paolo and Fierro, Tiziana and Morelli, Olivia and Laffi, Giacomo and Romanelli, Roberto Giulio and Arena, Umberto and Stasi, Cristina and Gasbarrini, Antonio and Garcovich, Matteo and Zocco, Maria Assunta and Riccardi, Laura and Ainora, Maria Elena and Capeci, William and Martino Giuseppe, Pio and Nobili, Lorenzo and Cavallo, Maurizio and Frugiuele, Pierluigi and Greco, Antonio and Ventura, Paolo and Cuoghi, Chiara and Marcacci, Matteo and Serviddio, Gaetano and Vendemiale, Gianluigi and Villani, Rosanna and Gargano, Ruggiero and Vidili, Gianpaolo and Di Cesare, Valentina and Masala, Maristella and Delitala, Giuseppe and Invernizzi, Pietro and Vincenzo, Ronca and Di Minno, Giovanni and Tufano, Antonella and ... and PRO-LIVER Collaborators
American Journal of Gastroenterology, ISSN 0002-9270, 03/2018, Volume 113, Issue 3, pp. 368 - 375
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2014, Volume 166, Issue 1, pp. 118 - 129
Journal Article